Abstract:Naturally occurring protein switches have been repurposed for developing novel biosensors and reporters for cellular and clinical applications1, but the number of such switches is limited, and engineering them is often challenging as each is different. Here, we show that a very general class of protein-based biosensors can be created by inverting the flow of information through de novo designed protein switches in which binding of a peptide key triggers biological outputs of interest2. The designed sensors are modular molecular devices with a closed dark state and an open luminescent state; binding of the analyte of interest drives switching from the closed to the open state. Because the sensor is based purely on thermodynamic coupling of analyte binding to sensor activation, only one target binding domain is required, which simplifies sensor design and allows direct readout in solution. We demonstrate the modularity of this platform by creating biosensors that, with little optimization, sensitively detect the anti-apoptosis protein Bcl-2, the IgG1 Fc domain, the Her2 receptor, and Botulinum neurotoxin B, as well as biosensors for cardiac Troponin I and an anti-Hepatitis B virus (HBV) antibody that achieve the sub-nanomolar sensitivity necessary to detect clinically relevant concentrations of these molecules. Given the current need for diagnostic tools for tracking COVID-193, we used the approach to design sensors of antibodies against SARS-CoV-2 protein epitopes and of the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein. The latter, which incorporates a de novo designed RBD binder4, has a limit of detection of 15 pM and a signal over background of over 50-fold. The modularity and sensitivity of the platform should enable the rapid construction of sensors for a wide range of analytes and highlights the power of de novo protein design to create multi-state protein systems with new and useful functions.

De novo-designed minibinders expand the synthetic biology sensing repertoire

De novo design of modular and tunable protein biosensors

Conversion of natural cytokine receptors into orthogonal synthetic biosensors

Cell-free immuno-profiling on a genetically programmed biochip

Synthetic GPCRs for programmable sensing and control of cell behaviour

Synthetic G protein-coupled receptors for programmable sensing and control of cell behavior

Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor

Programmable synthetic receptors: the next-generation of cell and gene therapies.

Modular design of synthetic receptors for programmed gene regulation in cell therapies

Biological Applications of Synthetic Binders Isolated from a Conceptually New Adhiron Library

Engineered Receptors for Soluble Cell-to-Cell Communication

Toward high-throughput engineering techniques for improving CAR intracellular signaling domains

Engineered receptors for soluble cellular communication and disease sensing

De novo-designed transmembrane domains tune engineered receptor functions

De novo design of protein minibinder agonists of TLR3

Sybodies as Novel Bioreceptors toward Field-Effect Transistor-Based Detection of SARS-CoV-2 Antigens

Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants

De novo design of high-affinity binders of bioactive helical peptides

Design of high specificity binders for peptide-MHC-I complexes

A Proximity-Dependent Biosensor System for Visualizing Cell-Cell Interactions Induced by Therapeutic Antibodies

De novo designed pMHC binders facilitate T cell induced killing of cancer cells